Skip to main content

Table 4 Comparison of seroprevalence of HBsAg and anti-HBs in “the same school” and “the others” groups

From: Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study

Item

18-year age group (birth cohort 1993–1994)

 

The same school (n = 38)

The others (n = 1256)

P-value

Anti-HBs (+), n (%, 95% CI)

29 (76.3, 62.8-89.8)

499 (39.7, 37.0-42.4)

<0.001*

Anti-HBs (−), n (%, 95% CI)

9 (23.7, 10.2-37.2)

757 (60.3, 57.6-63.0)

Anti-HBs titer, mean ± SD (median)

157.6 ± 281.3 (P50 = 24.7)

58.8 ± 145.9 (P50 = 4.2)

<0.001*

HBsAg (+), n (%)

0 (0.0)

10 (0.8%)

0.581

HBsAg (−), n (%)

38 (100.0)

1246 (99.2%)

 
  1. Data are presented as n and percentage or mean ± standard deviation (median).
  2. *p-value < 0.05 was considered statistically significant after test.